August - 2010
| Previous Next | Showing Journal 9 of 12 |
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.Todd W. Rice et al. Critical Care Medicine , 2010, 38:1685-1694 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
August |
Previous Comments
No Comments yet.
Comment